Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General bacterial and follicular cellular components is a broad term encompassing the various biological structures within the hair follicle and sebaceous gland that contribute to the pathogenesis of acne vulgaris. This includes the microflora, specifically Cutibacterium acnes (formerly Propionibacterium acnes), and its structural proteins, as well as the host's follicular keratinocytes and sebocytes (PubMed: 28274357). Drugs targeting these components, such as benzoyl peroxide, typically act through non-specific mechanisms like the generation of reactive oxygen species to induce bacterial cell death or by altering the keratinization process to prevent pore blockage (StatPearls: NBK537222). Other treatments like topical antibiotics inhibit bacterial protein synthesis within this environment (NIH: PMC3080563). Because this designation refers to a complex anatomical and microbial site rather than a specific protein or receptor, it is not considered a discrete molecular therapeutic target.
Non-specific oxidation of bacterial proteins and modulation of follicular epithelial cell turnover.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General bacterial and follicular cellular components.